financetom
Business
financetom
/
Business
/
Market Chatter: Nutrien Plans Exit From Argentina, Chile
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Nutrien Plans Exit From Argentina, Chile
Apr 15, 2024 3:28 AM

06:10 AM EDT, 04/15/2024 (MT Newswires) -- Nutrien Ltd. ( NTR ) , the world's largest maker of fertilizers, said it is seeking to sell its retail operations in Argentina, Chile and Uruguay in order to focus on Brazil and other global markets, Bloomberg reported Friday

The Canadian company is prioritizing key markets in a bid to boost returns for investors, a spokesperson said in an emailed statement to Bloomberg.

According to the report, "Nutrien ( NTR ), which has been in South America for more than a quarter of a century, is working to recover after sharply missing profit expectations in the last three months of 2023 amid plunging fertilizer prices that hurt retail results.

"The company said in its annual report that Argentina's currency controls meant it lost money when it transferred currency out of the country because it had to use a more expensive exchange rate. New President Javier Milei has promised to scrap the controls as he seeks to deregulate the economy.

"Its exit from the Argentine retail business comes as the country seeks to cheapen the herbicide and fertilizer market for farmers by reducing import taxes on both inputs.

"Other companies have also abandoned Argentina's tough business environment in recent years, including HSBC Holdings PLC and Walmart Inc. Bayer AG ditched its Argentine soy seed business in 2021.

"Nutrien ( NTR ) didn't say what it's planning to do with its 50% stake in Profertil SA, a urea and ammonia manufacturing venture it has with Argentina state-run oil company YPF SA. YPF, under new management appointed by Milei, is looking to divest assets to focus on shale drilling."

Nutrien ( NTR ) on Friday said it would continue to support all customers and partners through its divestiture process.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
CoStar Group Q4 Earnings Fall, Revenue Rises; 2025 Revenue Outlook Set -- Shares Fall after-Hours
CoStar Group Q4 Earnings Fall, Revenue Rises; 2025 Revenue Outlook Set -- Shares Fall after-Hours
Feb 18, 2025
04:23 PM EST, 02/18/2025 (MT Newswires) -- CoStar Group ( CSGP ) reported Q4 earnings late Tuesday of $0.15 per diluted share, down from $0.24 a year ago. Analysts surveyed by FactSet expected $0.13. Revenue for the quarter ended Dec. 31 was $709.4 million, up from $640.1 million a year earlier. Analysts polled by FactSet expected $701 million. The company...
Penumbra Q4 Non-GAAP Earnings, Revenue Rise; Sets 2025 Guidance
Penumbra Q4 Non-GAAP Earnings, Revenue Rise; Sets 2025 Guidance
Feb 18, 2025
04:23 PM EST, 02/18/2025 (MT Newswires) -- Penumbra (PEN) reported Q4 non-GAAP earnings late Tuesday of $0.97 per diluted share, up from $0.76 a year earlier. Analysts polled by FactSet expected $0.90. Revenue for the quarter ended Dec. 31 was $315.5 million, up from $284.7 million a year earlier. Analysts expected $311.4 million. The company expects full-year 2025 revenue between...
Occidental Petroleum reports fourth-quarter loss
Occidental Petroleum reports fourth-quarter loss
Feb 18, 2025
(Reuters) - Occidental Petroleum ( OXY ) reported a fourth-quarter loss on Tuesday, as the oil and gas firm was hurt by lower prices. The company reported a loss of $297 million for the quarter ended December 31, compared with a profit of $1.03 billion from a year earlier. (Reporting by Tanay Dhumal in Bengaluru; Editing by Anil D'Silva) ...
Halozyme Therapeutics Q4 Non-GAAP EPS, Revenue Increase
Halozyme Therapeutics Q4 Non-GAAP EPS, Revenue Increase
Feb 18, 2025
04:23 PM EST, 02/18/2025 (MT Newswires) -- Halozyme Therapeutics ( HALO ) reported Q4 non-GAAP earnings Tuesday of $1.26 per diluted share, up from $0.82 a year earlier. Analysts polled by FactSet expected $1.13 Revenue in the three months ended Dec. 31 rose to $298 million from $230 million a year earlier. Analysts surveyed by FactSet expected $285.7 million. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved